Gerosciences Axis


819 821-0000 , 75214

Full Professor
Department of Microbiology and Infectiology
Faculty of Medicine and Health Sciences
Université de Sherbrooke
Chairholder: Canada Research Chair in Telomere Biology


Postdoc in Molecular Genetics
Ph.D. Molecular Biology
Master's Biology

Research Themes

Telomere Biology
Researcher Raymund J. Wellinger is interested in the duplication stages of genetic materials, particularly those of structures at the end of chromosomes known as telomeres.

The results of Dr. Wellinger's studies will help us to gain a better understanding of phenomena which enable human cancer cells to remain quasi immortal, compared to other cells in the body which appear to have a predetermined lifespan. These results will contribute to new cancer therapies and will be relevant in our understanding of the molecular mechanisms of cell death (senescence).

Dr. Wellinger completed his Ph.D. in molecular biology at the Swiss Institute for Experimental Cancer Research (ISREC), which is affiliated with the Université de Lausanne (Switzerland, 1986), and his postdoctoral studies at the Fred Hutchinson Cancer Research Center (Seattle, USA, 1993).

He also co-founded and served as Vice-President for Research (VPR) for the biotechnology firm Telogene Inc. He is credited with numerous international collaborative initiatives, five patents, and numerous publications in prestigious scientific journals, notably Cell, Nature, and Science.

As a result of his leadership at the international level, Dr. Wellinger regularly sits on prestigious peer review committees entrusted with assigning research grants, including those of the U.S. National Institutes of Health (NIH) and the Canadian Institutes of Health Research (CIHR). In addition, he has served on the board of the Fonds de Recherche en Santé du Québec.

Finally, Dr Wellinger peer reviews and serves as an advisor in the selection of articles submitted for publication with numerous, world-renowned scientific journals, among them Science, Cell, Nature, Genes and Development, Molecular and Cellular Biology, and Proceedings of the National Academy of Sciences (USA).

Representative Achievements
• 1998, Discovery of the Year Award (Quebec Science; with Prof. B. Chabot)
• 2000, Co-founded Telogene Inc., $2.5M investment in private capital
• 2001, National Researcher Award by the Fonds de Recherche en Santé du Québec (FRSQ)
• 2005, Co-Researcher at the Functional Genomics Laboratory of the UdeS, funded by Genome Canada/Génome Québec ($10.5M over four years)
• 1994-present, Obtained research grants totalling $350K annually from the Canadian Institutes of Health Research (CIHR) and the National Cancer Institute of Canada.
• 2009-2023, Canada Research Chair in Telomere Biology

• Specialist in molecular engineering and classical genetics.
• Specialist in the fundamental mechanisms leading to oncogenesis.
• Specialist in the genetic and genomic interactions of cancer.


Return to researchers list